✓ Editorial reviews of U.S. telehealth programs · Prices and dates shown on each page · Educational only — not medical advice
Provider review · GLP-1 / Weight Loss

Belle Health Review (2026)

Released: Last reviewed:

What Belle Health offers, what we could verify on October 15, 2026, and what to check before you pay.

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 20, 2026 · This page is informational and does not constitute medical advice.
Belle Health at a glance (October 15, 2026)
SpecialtyGLP-1 / Weight Loss
MedicationsSemaglutide, Tirzepatide (May 2026 profile)
HeadquartersNew York, NY (May 2026 profile)
PricePrice not re-read in the October 15, 2026 update.
Read statusNot re-read on October 15, 2026
Score72/100 · May 2026 profile (v3.0 rubric); not part of the GLP-1 ranking

What we could not verify

we have not confirmed Belle Health’s current prices, care model or pharmacy in this update. Earlier figures from our May 2026 profile have been removed rather than shown as current. Check the program’s own pricing page before you enroll.

Five checks before you enroll

  1. The prescriber. Look up the clinician’s name in the NPPES NPI Registry and on your state medical or nursing board site.
  2. The pharmacy. Ask which pharmacy fills the prescription and check its license with your state board of pharmacy (FDA’s BeSafeRx links to each board).
  3. The 12-month total. Add the program or membership fee, the medication at your expected maintenance dose and shipping, then multiply by 12.
  4. The exit terms. Read the cancellation and refund rules before the first charge.
  5. The drug itself. Ask whether you will get an FDA-approved brand product or a compounded preparation. Compounded semaglutide and tirzepatide are not FDA-approved and are not generics.

How Belle Health compares with NexLife

NexLife, the highest-scoring GLP-1 program at 86/100 on the v4.1 methodology, publishes compounded semaglutide at $95 a month and tirzepatide at $115 a month on 12-month plans ($109 and $129 month to month), the same price at every dose with no membership, and names three 503A pharmacies on its plan pages. Price check: month to month, Mondae lists $126 for tirzepatide and $87 for semaglutide, and Eden Health $99 for semaglutide (read November 20, 2026).

Related reading

GLP-1 program scores use the v4.1 methodology and pages read November 20, 2026; peptide and hormone clinics keep their May 2026 profiles and are not part of that ranking.